Skip to main content
Industry News
Veterinary vaccine maker takes on COVID-19

Veterinary vaccine developer MBF Therapeutics is partnering with four other firms to develop a COVID-19 vaccine. MBF's vaccines are based on checkpoint inhibitors and induce production of T cells against multiple antigens, says CEO Thomas Tillett.

Full Story: